ACTUALIDAD

A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration

 

INVESTIGADOR:

Dr. Álvaro Fernández-Vega Sanz

 RECLUTANDO 

 

A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration.


PATOLOGÍA: DMAE
TRATAMIENTO: Conbercept
CÓDIGO DE ESTUDIO: PANDA
PROMOTOR: Chengdu Kanghong Biotechnology Co, Ltd.

(Klonopin)

Déjanos tus datos
Nos pondremos en contacto contigo